N Le Bail
Impact in
- Hepatology top 0.5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Oncology top 0.5%
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
- Colorectal Cancer Surgical Treatments
Papers in
- Oncology 21
- Cancer Treatment and Pharmacology 15
- Colorectal Cancer Treatments and Studies 13
-
- Hepatocellular Carcinoma Treatment and Prognosis 2
- Co-authors
- Christophe LouvetAimery de GramontD. PapamichaelM. HomerinH. Cortés-FunesMichel SeymourC. BoniAndrés Cervantes
- Journals
- European Journal of Cancer (6 papers)Journal of Clinical Oncology (5 papers)Cancer Chemotherapy and Pharmacology (3 papers)British Journal of Cancer (1 paper)Investigational New Drugs (1 paper)
- Partner nations
- FranceUnited StatesGreece
In The Last Decade
N Le Bail
23 papers receiving 5.3k citations
Hit Papers
Peers
Comparison fields: 5 of 107
- Hepatology 1.5k
- Oncology 4.7k
- Pulmonary and Respiratory Medicine 1.4k
- Pathology and Forensic Medicine 718
- Dermatology 328
Countries citing papers authored by N Le Bail
This map shows the geographic impact of N Le Bail's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N Le Bail with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N Le Bail more than expected).
Fields of papers citing papers by N Le Bail
This network shows the impact of papers produced by N Le Bail. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N Le Bail. The network helps show where N Le Bail may publish in the future.
Co-authors
The 25 scholars most cited alongside N Le Bail, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 4 | |
| 2 | 2017 | 2 | |
| 3 | Superiority of Oxaliplatin and Fluorouracil-Leucovorin Compared With Either Therapy Alone in Patients With Progressive Colorectal Cancer After Irinotecan and Fluorouracil-Leucovorin: Interim Results of a Phase III Trial Hit paper breakdown → | 2003 | 510 |
| 4 | Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer Hit paper breakdown → | 2000 | 3040 |
| 5 | Phase III Multicenter Randomized Trial of Oxaliplatin Added to Chronomodulated Fluorouracil–Leucovorin as First-Line Treatment of Metastatic Colorectal Cancer Hit paper breakdown → | 2000 | 1102 |
| 6 | Oxaliplatin, leucovorin and fluorouracil in pretreated patients with advanced colorectal cancer. | 1997 | 1 |
| 7 | 1997 | 311 | |
| 8 | 1997 | 33 | |
| 9 | 1995 | 15 | |
| 10 | 1995 | 49 | |
| 11 | 1994 | 22 | |
| 12 | 1994 | 2 | |
| 13 | Phase I and pharmacokinetic study of Taxotere (RP 56976; NSC 628503) given as a short intravenous infusion. | 1993 | 227 |
| 14 | Phase I and pharmacokinetic study of taxotere (RP 56976) administered as a 24-hour infusion. | 1993 | 123 |
| 15 | 1993 | 5 | |
| 16 | 1993 | 2 | |
| 17 | Unexpected pleural changes observed in patients treated with Taxotere (RP 56976) : A new drug toxicity ? | 1992 | 1 |
| 18 | Phase I pharmacokinetic (PK) study of Taxotere (T) (RP56976, NSC628503) administered as a weekly infusion | 1992 | 2 |
| 19 | A phase I study of Taxotere (RP 56976 NSC 628503) administered as a one hour intravenous infusion on a weekly basis | 1991 | 12 |
| 20 | 1987 | 22 |
About N Le Bail
N Le Bail is a scholar working on Oncology, Hepatology, Otorhinolaryngology, Dermatology and Pathology and Forensic Medicine, having authored 23 papers that have together received 5.5k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (15 papers), Colorectal Cancer Treatments and Studies (13 papers), Genetic factors in colorectal cancer (4 papers), Lung Cancer Treatments and Mutations (4 papers), Cancer therapeutics and mechanisms (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Glioma Diagnosis and Treatment (2 papers) and Gastric Cancer Management and Outcomes (2 papers). The work is most often cited by research in Hepatology (1.5k citations), Oncology (4.7k citations), Pulmonary and Respiratory Medicine (1.4k citations), Pathology and Forensic Medicine (718 citations) and Dermatology (328 citations). N Le Bail has collaborated with scholars based in France, United States and Greece. Frequent co-authors include Christophe Louvet, Aimery de Gramont, D. Papamichael, M. Homerin, H. Cortés-Funes, Michel Seymour, C. Boni, Andrés Cervantes, Jim Cassidy and Abdel Hmissi. Their work appears in journals such as European Journal of Cancer, Journal of Clinical Oncology, Cancer Chemotherapy and Pharmacology, British Journal of Cancer and Investigational New Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.